PATIENT HEALTH IS OUR FOCUS, MEDICAL EXCELLENCE IS OUR GOAL
Apriline® product range is designed with the patients’ safety and skin health in mind and made in accordance with the highest quality standards of cosmetics and medical device manufacturing (ISO 22716, ISO 13485 and GMP).
We guarantee maximum effectiveness and sustainability through stringent, continuous testing of our products.
CLINICALLY PROVEN EFFICACY
Apriline® Meso complex is created using the unique and powerful CHAC Technology . Thanks to this, the obtained molecular complexes are highly stable and provide long-lasting aesthetic results.
3 treatment sessions: D0 D30 D60
Product tested: Apriline® AGEline
Treatment tool: Sterile medical roller containing 540, 1mm long, fine needles was applied using light pressure on all areas of the face.
Treated area: jawline, nasolabial folds, cheeks, under the eyes area.
Clinical evaluation: Independent clinical study conducted by GREDECO Laboratory, France. Led by Dr. Boisnic and Dr. Paraskevov. Results based on 2 and 3 sessions with 30 days interval.
* The radiance of the skin was evaluated with: (1) 2D and 3D photography using device Life Viz II and Life Viz Micro; (2) Clinical evaluation dermatological scores from 0 to 4 (score 1 corresponding to a luminous skin and 4 to a dull complexion).
** Dermis density was measured using the Monaderm ultrasound (2D 20 MHz probe, 12.1 mm narrow-focus exploration and advanced Control acquisition and analysis software).
CLINICALLY PROVEN EFFICACY
Apriline® Fillers are CE- marked injectable gels based on the Hyaluronic Acid developed by scientists with a long track record in Hyaluronic Acid research.
Thanks to the advanced one phase manufacturing process, the purity of Apriline® Fillers and BDDE rate are well beyond the strict EU requirements. Applications are safe and comfortable for patients whilst also easy to administer and control by physicians.
25 healthy patients, average age: 54.16+-
Product tested: Apriline® Forte
Injection area: left and right nasolabial folds
Injection volume: 0,8 per each side
Injection technique: retrograde (needle)
Evaluation at 1, 2, 3 and 9 months
Clinical evaluation: Independent clinical study conducted by GREDECO Laboratory, France. Led by Dr. Boisnic and Dr. Paraskevov with the latter performing all the injections.
WORKING WITH SUISSELLE
Want to work with Apriline® products?
Please send us an email with your contact details at firstname.lastname@example.org or fill the contact form, our Sales team will contact you.
We take pride in providing the best quality service to all of our distributors through continuous education, reward programs, exclusive events and full-scale marketing support.